Cargando…
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys
BACKGROUND: Rwanda was the first African country to implement national human papillomavirus (HPV) vaccination (against types HPV6, 11, 16, and 18). In 2011, a school-based catch-up programme was initiated to vaccinate girls aged younger than 15 years but it also reached older girls in schools. We ai...
Autores principales: | Sayinzoga, Felix, Tenet, Vanessa, Heideman, Daniëlle A M, Sibomana, Hassan, Umulisa, Marie-Chantal, Franceschi, Silvia, Hakizimana, Jean de Dieu, Clifford, Gary M, Baussano, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282073/ https://www.ncbi.nlm.nih.gov/pubmed/37207683 http://dx.doi.org/10.1016/S2214-109X(23)00193-6 |
Ejemplares similares
-
Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
por: Sayinzoga, Felix, et al.
Publicado: (2020) -
Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
por: Baussano, Iacopo, et al.
Publicado: (2021) -
Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
por: Umulisa, M. Chantal, et al.
Publicado: (2018) -
Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019) -
Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
por: Ngabo, Fidele, et al.
Publicado: (2016)